Clinical Trial Update: Impact of Neoadjuvant Immunotherapy in Early Stage Breast Cancer Before Standard Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant immunotherapy for early-stage breast cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED